Correction: Phase I clinical study of the recombinant antibody-toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

Detalles Bibliográficos
Autores principales: von Minckwitz, Gunter, Harder, Sebastian, Hövelmann, Sascha, Jäger, Elke, Al-Batran, Salah-Eddin, Loibl, Sibylle, Atmaca, Akin, Cimpoiasu, Christian, Neumann, Antje, Abera, Aklil, Knuth, Alexander, Kaufmann, Manfred, Jäger, Dirk, Maurer, Alexander B, Wels, Winfried S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413982/
http://dx.doi.org/10.1186/bcr1390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413982/
http://dx.doi.org/10.1186/bcr1390

Ejemplares similares